Ally Bridge Group’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,075
Closed -$6.24M 27
2024
Q1
$6.24M Buy
+20,075
New +$6.24M 3.47% 16